212 related articles for article (PubMed ID: 34990780)
1. A 10-step framework for use of read-across (RAX) in next generation risk assessment (NGRA) for cosmetics safety assessment.
Alexander-White C; Bury D; Cronin M; Dent M; Hack E; Hewitt NJ; Kenna G; Naciff J; Ouedraogo G; Schepky A; Mahony C; Europe C
Regul Toxicol Pharmacol; 2022 Mar; 129():105094. PubMed ID: 34990780
[TBL] [Abstract][Full Text] [Related]
2. Read-across and new approach methodologies applied in a 10-step framework for cosmetics safety assessment - A case study with parabens.
Ouedraogo G; Alexander-White C; Bury D; Clewell HJ; Cronin M; Cull T; Dent M; Desprez B; Detroyer A; Ellison C; Giammanco S; Hack E; Hewitt NJ; Kenna G; Klaric M; Kreiling R; Lester C; Mahony C; Mombelli E; Naciff J; O'Brien J; Schepky A; Tozer S; van der Burg B; van Vugt-Lussenburg B; Stuard S; Cosmetics Europe
Regul Toxicol Pharmacol; 2022 Jul; 132():105161. PubMed ID: 35508214
[TBL] [Abstract][Full Text] [Related]
3. New framework for a non-animal approach adequately assures the safety of cosmetic ingredients - A case study on caffeine.
Bury D; Alexander-White C; Clewell HJ; Cronin M; Desprez B; Detroyer A; Efremenko A; Firman J; Hack E; Hewitt NJ; Kenna G; Klaric M; Lester C; Mahony C; Ouedraogo G; Paini A; Schepky A;
Regul Toxicol Pharmacol; 2021 Jul; 123():104931. PubMed ID: 33905778
[TBL] [Abstract][Full Text] [Related]
4. Internationalization of read-across as a validated new approach method (NAM) for regulatory toxicology.
Rovida C; Barton-Maclaren T; Benfenati E; Caloni F; Chandrasekera PC; Chesné C; Cronin MTD; De Knecht J; Dietrich DR; Escher SE; Fitzpatrick S; Flannery B; Herzler M; Hougaard Bennekou S; Hubesch B; Kamp H; Kisitu J; Kleinstreuer N; Kovarich S; Leist M; Maertens A; Nugent K; Pallocca G; Pastor M; Patlewicz G; Pavan M; Presgrave O; Smirnova L; Schwarz M; Yamada T; Hartung T
ALTEX; 2020; 37(4):579-606. PubMed ID: 32369604
[TBL] [Abstract][Full Text] [Related]
5. COSMOS next generation - A public knowledge base leveraging chemical and biological data to support the regulatory assessment of chemicals.
Yang C; Cronin MTD; Arvidson KB; Bienfait B; Enoch SJ; Heldreth B; Hobocienski B; Muldoon-Jacobs K; Lan Y; Madden JC; Magdziarz T; Marusczyk J; Mostrag A; Nelms M; Neagu D; Przybylak K; Rathman JF; Park J; Richarz AN; Richard AM; Ribeiro JV; Sacher O; Schwab C; Vitcheva V; Volarath P; Worth AP
Comput Toxicol; 2021 Aug; 19():100175. PubMed ID: 34405124
[TBL] [Abstract][Full Text] [Related]
6. Application of physiologically based kinetic (PBK) modelling in the next generation risk assessment of dermally applied consumer products.
Moxon TE; Li H; Lee MY; Piechota P; Nicol B; Pickles J; Pendlington R; Sorrell I; Baltazar MT
Toxicol In Vitro; 2020 Mar; 63():104746. PubMed ID: 31837441
[TBL] [Abstract][Full Text] [Related]
7. Development of a next generation risk assessment framework for the evaluation of skin sensitisation of cosmetic ingredients.
Gilmour N; Kern PS; Alépée N; Boislève F; Bury D; Clouet E; Hirota M; Hoffmann S; Kühnl J; Lalko JF; Mewes K; Miyazawa M; Nishida H; Osmani A; Petersohn D; Sekine S; van Vliet E; Klaric M
Regul Toxicol Pharmacol; 2020 Oct; 116():104721. PubMed ID: 32645429
[TBL] [Abstract][Full Text] [Related]
8. Towards grouping concepts based on new approach methodologies in chemical hazard assessment: the read-across approach of the EU-ToxRisk project.
Escher SE; Kamp H; Bennekou SH; Bitsch A; Fisher C; Graepel R; Hengstler JG; Herzler M; Knight D; Leist M; Norinder U; Ouédraogo G; Pastor M; Stuard S; White A; Zdrazil B; van de Water B; Kroese D
Arch Toxicol; 2019 Dec; 93(12):3643-3667. PubMed ID: 31781791
[TBL] [Abstract][Full Text] [Related]
9. Next generation risk assessment for occupational chemical safety - A real world example with sodium-2-hydroxyethane sulfonate.
Wood A; Breffa C; Chaine C; Cubberley R; Dent M; Eichhorn J; Fayyaz S; Grimm FA; Houghton J; Kiwamoto R; Kukic P; Lee M; Malcomber S; Martin S; Nicol B; Reynolds J; Riley G; Scott S; Smith C; Westmoreland C; Wieland W; Williams M; Wolton K; Zellmann T; Gutsell S
Toxicology; 2024 Jun; 506():153835. PubMed ID: 38857863
[TBL] [Abstract][Full Text] [Related]
10. Setting the stage for next-generation risk assessment with non-animal approaches: the EU-ToxRisk project experience.
Moné MJ; Pallocca G; Escher SE; Exner T; Herzler M; Bennekou SH; Kamp H; Kroese ED; Leist M; Steger-Hartmann T; van de Water B
Arch Toxicol; 2020 Oct; 94(10):3581-3592. PubMed ID: 32886186
[TBL] [Abstract][Full Text] [Related]
11. Incorporating integrated testing strategy (ITSv1) defined approach into read-across (RAx) in predicting skin sensitization potency: ITSv1-based RAx.
Nakayama K; Zifle A; Fritz S; Fuchs A; Sakaguchi H; Miyazawa M
Regul Toxicol Pharmacol; 2023 Mar; 139():105358. PubMed ID: 36805910
[TBL] [Abstract][Full Text] [Related]
12. Human biomonitoring and toxicokinetics as key building blocks for next generation risk assessment.
Reale E; Zare Jeddi M; Paini A; Connolly A; Duca R; Cubadda F; Benfenati E; Bessems J; S Galea K; Dirven H; Santonen T; M Koch H; Jones K; Sams C; Viegas S; Kyriaki M; Campisi L; David A; Antignac JP; B Hopf N
Environ Int; 2024 Feb; 184():108474. PubMed ID: 38350256
[TBL] [Abstract][Full Text] [Related]
13. Finding synergies for 3Rs - Toxicokinetics and read-across: Report from an EPAA partners' Forum.
Laroche C; Aggarwal M; Bender H; Benndorf P; Birk B; Crozier J; Dal Negro G; De Gaetano F; Desaintes C; Gardner I; Hubesch B; Irizar A; John D; Kumar V; Lostia A; Manou I; Monshouwer M; Müller BP; Paini A; Reid K; Rowan T; Sachana M; Schutte K; Stirling C; Taalman R; van Aerts L; Weissenhorn R; Sauer UG
Regul Toxicol Pharmacol; 2018 Nov; 99():5-21. PubMed ID: 30144470
[TBL] [Abstract][Full Text] [Related]
14. Next generation risk assessment for skin sensitisation: A case study with propyl paraben.
Assaf Vandecasteele H; Gautier F; Tourneix F; Vliet EV; Bury D; Alépée N
Regul Toxicol Pharmacol; 2021 Jul; 123():104936. PubMed ID: 33905779
[TBL] [Abstract][Full Text] [Related]
15. Read-across can increase confidence in the Next Generation Risk Assessment for skin sensitisation: A case study with resorcinol.
Gautier F; Tourneix F; Assaf Vandecasteele H; van Vliet E; Bury D; Alépée N
Regul Toxicol Pharmacol; 2020 Nov; 117():104755. PubMed ID: 32800849
[TBL] [Abstract][Full Text] [Related]
16. Applying a next generation risk assessment framework for skin sensitisation to inconsistent new approach methodology information.
Gilmour N; Alépée N; Hoffmann S; Kern PS; Van Vliet E; Bury D; Miyazawa M; Nishida H; Cosmetics Europe
ALTEX; 2023; 40(3):439-451. PubMed ID: 36919358
[TBL] [Abstract][Full Text] [Related]
17. Next Generation Risk Assessment of the Anti-Androgen Flutamide Including the Contribution of Its Active Metabolite Hydroxyflutamide.
van Tongeren TCA; Carmichael PL; Rietjens IMCM; Li H
Front Toxicol; 2022; 4():881235. PubMed ID: 35722059
[TBL] [Abstract][Full Text] [Related]
18. A hypothetical skin sensitisation next generation risk assessment for coumarin in cosmetic products.
Reynolds G; Reynolds J; Gilmour N; Cubberley R; Spriggs S; Aptula A; Przybylak K; Windebank S; Maxwell G; Baltazar MT
Regul Toxicol Pharmacol; 2021 Dec; 127():105075. PubMed ID: 34728330
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the predictive capacity of a physiologically based kinetic model using a read-across approach.
Paini A; Worth A; Kulkarni S; Ebbrell D; Madden J
Comput Toxicol; 2021 May; 18():100159. PubMed ID: 34027243
[TBL] [Abstract][Full Text] [Related]
20. Safety assessment of Cnidium officinale rhizome extract in cosmetics using the Threshold of Toxicological Concern (TTC) approach.
Jeon S; Lee EY; Hillman PF; Nam SJ; Lim KM
Regul Toxicol Pharmacol; 2023 Aug; 142():105433. PubMed ID: 37302562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
